In this video, Zarmeena Vendal, MD, presents: "Clinical Effect of the Addition of Netarsudil 0.02% Vs Brimonidine 0.1% in Normal Tension Glaucoma Patients Currently on Latanoprost 0.005%".

Watch this Clinical Study video: Evolving First-Line Glaucoma Treatment: Directive Selective Laser Trabeculoplasty (DSLT)

A roundtable discussion exploring Rho kinase inhibitors that target the conventional outflow pathway.